These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3858193)

  • 1. [Significance of prognostic factors in the evaluation of resistance to therapy of patients with lymphoblastic leukemia].
    Zedginidze ISh; Zodelava MM; Sheklashvili MSh; Zedginidze AG; Shvelidze TI
    Gematol Transfuziol; 1985 Apr; 30(4):16-9. PubMed ID: 3858193
    [No Abstract]   [Full Text] [Related]  

  • 2. Controversies in the management of childhood acute lymphoblastic leukemia: treatment intensification, CNS leukemia, and prognostic factors.
    Rivera GK; Mauer AM
    Semin Hematol; 1987 Jan; 24(1):12-26. PubMed ID: 3547669
    [No Abstract]   [Full Text] [Related]  

  • 3. [Factors influencing the prognosis of lymphoblastic leukemia in children].
    Vargas L; Barría M; Young T; Pino S; García H
    Rev Chil Pediatr; 1984; 55(3):156-63. PubMed ID: 6594727
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapidly rotating combination chemotherapy in childhood acute lymphoblastic leukemia: preliminary results of a randomized comparison with conventional treatment.
    Janka-Schaub GE; Winkler K; Göbel U; Graubner U; Gutjahr P; Haas RJ; Jürgens H; Spaar J
    Leukemia; 1988 Dec; 2(12 Suppl):73S-78S. PubMed ID: 3199881
    [No Abstract]   [Full Text] [Related]  

  • 5. Stratification by prognostic factors in the design and analysis of clinical trials for acute lymphoblastic leukemia.
    Hammond GD; Sather H; Bleyer WA; Coccia P
    Haematol Blood Transfus; 1987; 30():161-6. PubMed ID: 3305192
    [No Abstract]   [Full Text] [Related]  

  • 6. [Polyamine level as a possible criterion for the evaluation of resistance to chemotherapy of children with acute leukemia].
    Koftunova ME; Voronchikhina LD; Riabova TI; Riabov NV
    Gematol Transfuziol; 1987 Aug; 32(8):31-3. PubMed ID: 3479376
    [No Abstract]   [Full Text] [Related]  

  • 7. Glucocorticoid receptors and steroid sensitivity of human acute lymphoblastic leukemia.
    Iacobelli S; Marchetti P; De Rossi G; Mandelli F
    Prog Clin Biol Res; 1984; 142():235-46. PubMed ID: 6584926
    [No Abstract]   [Full Text] [Related]  

  • 8. Acute lymphoblastic leukaemia in adults (response to treatment and prognostic factors).
    Koppikar SB; Giri NK; Advani SH; Nair CN; Gopal R; Nadkarni KS; Pai VR; Saikia T; Kurkure PA; Pai SK
    Indian J Cancer; 1987 Jun; 24(2):118-24. PubMed ID: 3480266
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment results in acute lymphoblastic leukemia in children].
    Makhonova LA; Maiakova SA
    Gematol Transfuziol; 1987 Feb; 32(2):3-7. PubMed ID: 3470234
    [No Abstract]   [Full Text] [Related]  

  • 10. [Duration of remission after termination of treatment of lymphoblastic leukemia in children].
    Nosek-Cenkowska B; Armata J
    Pol Tyg Lek; 1984 Feb; 39(7):205-8. PubMed ID: 6589588
    [No Abstract]   [Full Text] [Related]  

  • 11. [Type L1 acute lymphoblastic leukemia in children].
    Rivera Luna R; Martínez Guerra G; Borrego Román R; Rivera Márquez H
    Rev Invest Clin; 1984; 36(1):23-9. PubMed ID: 6585873
    [No Abstract]   [Full Text] [Related]  

  • 12. Risk groups in adult acute lymphoblastic leukemia.
    Hoelzer D; Thiel E; Löffler H; Ganser A; Heimpel H; Büchner T; Urbanitz D; Koch P; Freund M; Diedrich H
    Haematol Blood Transfus; 1987; 30():104-10. PubMed ID: 3305188
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of acute lymphoblastic leukemia in children with the BFM protocol: a cooperative study and analysis of prognostic factors.
    Maurus R; Boilletot A; Otten J; Philippe N; Benoit Y; Behar C; Casteels-Van Daele M; Chantraine JM; Delbeke MJ; Gyselinck J
    Haematol Blood Transfus; 1987; 30():466-70. PubMed ID: 3305214
    [No Abstract]   [Full Text] [Related]  

  • 14. [Course of acute lymphoblastic leukemia with marked initial hyperleukocytosis at a young age].
    Berliner GB; Arkavina EA; Polezhaev IuN
    Gematol Transfuziol; 1985 Apr; 30(4):23-5. PubMed ID: 3858195
    [No Abstract]   [Full Text] [Related]  

  • 15. [Current problems in the treatment of adult acute lymphoid leukemia].
    Mód A; Poros A; Hollán Z
    Orv Hetil; 1988 Jul; 129(28):1469-74. PubMed ID: 3047623
    [No Abstract]   [Full Text] [Related]  

  • 16. [Analysis of advances in the treatment of lymphoblastic leukemia].
    Korczowski R; Jakieła T
    Pediatr Pol; 1985 Jan; 60(1):15-9. PubMed ID: 3862055
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute lymphoblastic leukemia: current status of therapy in children.
    Lampert F; Henze G; Langermann HJ; Schellong G; Gadner H; Riehm HJ
    Recent Results Cancer Res; 1984; 93():159-81. PubMed ID: 6382478
    [No Abstract]   [Full Text] [Related]  

  • 18. Prognostic factors in acute lymphoblastic leukemia in adults: the Memorial Hospital experience.
    Andreeff M; Gaynor J; Chapman D; Little C; Gee T; Clarkson BD
    Haematol Blood Transfus; 1987; 30():111-24. PubMed ID: 3476352
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical experiences with a modified BFM protocol in childhood acute lymphoblastic leukemia.
    Zintl F; Malke H; Plenert W
    Haematol Blood Transfus; 1985; 29():84-9. PubMed ID: 3896979
    [No Abstract]   [Full Text] [Related]  

  • 20. Acute lymphoblastic leukemia in a young adult.
    Mauer AM
    Hosp Pract (Off Ed); 1987 Sep; 22(9):145-50, 155-62. PubMed ID: 3114285
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.